-
Views
-
Cite
Cite
Kenneth E. Aldridge, A New Potent β-Lactamase Inhibitor, BRL 42715, with Inherent Activity Against Bacteroides fragilis Group Strains, Clinical Infectious Diseases, Volume 16, Issue Supplement_4, June 1993, Pages S335–S338, https://doi.org/10.1093/clinids/16.Supplement_4.S335
- Share Icon Share
This content is only available as a PDF.
© 1993 by The University of Chicago
Topic:
Issue Section:
Susceptibility Testing
You do not currently have access to this article.